TELA Bio, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
TELA Nasdaq 3850 www.telabio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for TELA Bio, Inc.

Aroa Biosurgery Ltd (AROAF) (FY25) Earnings Call Highlights: Surpassing Revenue Expectations ... - Jun 7th, 2025 9:01 pm
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Jun 6th, 2025 2:05 pm
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair - Jun 3rd, 2025 2:05 pm
TELA Bio Appoints Jeffrey Blizard as President - Jun 2nd, 2025 6:30 am
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference - May 22nd, 2025 2:05 pm
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9th, 2025 2:05 pm
TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges - May 9th, 2025 1:41 am
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates - May 8th, 2025 3:45 pm
TELA Bio Reports First Quarter 2025 Financial Results - May 8th, 2025 2:05 pm
Favourable Signals For TELA Bio: Numerous Insiders Acquired Stock - May 2nd, 2025 5:05 am
TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ... - Apr 21st, 2025 2:28 pm
TELA Bio to Announce First Quarter 2025 Financial Results - Apr 17th, 2025 2:05 pm
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery - Mar 31st, 2025 5:00 am
TELA Bio Full Year 2024 Earnings: Revenues Disappoint - Mar 22nd, 2025 7:27 am
TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover - Mar 21st, 2025 12:26 pm
TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates - Mar 20th, 2025 4:50 pm
TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results - Mar 20th, 2025 2:05 pm
TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results - Feb 27th, 2025 2:05 pm
Retail investors account for 41% of TELA Bio, Inc.'s (NASDAQ:TELA) ownership, while institutions account for 28% - Jan 12th, 2025 5:28 am
The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable - Dec 1st, 2024 5:27 am